CNR1 and triple-negative breast carcinoma: In triple-negative breast cancer (TNBC), CNR1 regulates fatty acid metabolism by modulating the PI3K-AKT/MAPK signaling pathways, thereby affecting the sensitivity of cells toward ferroptosis (Li et al., 2022).